We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GFI:JSEGold Fields Limited Analysis

Data as of 2026-05-25 - not real-time

ZAC 63,918.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Gold Fields (GFI.JO) is trading at ZAc 63,918, well below its 20‑day (ZAc 70,985), 50‑day (ZAc 74,537) and 200‑day (ZAc 73,025) simple moving averages, with an RSI of 34 indicating oversold conditions. The MACD remains bearish and the price sits just above a key support level of ZAc 63,235, while the next resistance sits near ZAc 78,157. Despite the technical weakness, the company boasts robust fundamentals: revenue growth of 71%, gross margins of 55%, operating margins of 52%, a trailing PE of 9.85 (forward PE 6.35), ROE of 52%, dividend yield of 3.99% with a modest 20% payout, and a low net‑debt profile. These metrics suggest significant upside potential.
Recent analyst activity includes a Canaccord upgrade to Buy and a raised price target, alongside notable insider buying, which adds confidence to the upside narrative. While the firm flagged rising mining costs and potential oil‑price shocks, its strong cash generation, low beta (≈0.36) and a DCF‑derived upside of roughly 47% support a bullish stance for medium‑ to long‑term investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support and oversold RSI
  • Bearish MACD momentum
  • Recent upgrade and insider buying provide upside catalyst

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong earnings margins and low PE multiples
  • Sustainable dividend yield of ~4% with low payout ratio
  • Analyst upgrade to Buy and raised price target

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • High ROE and cash flow generation supporting growth
  • Gold as a long‑term inflation hedge
  • Undervalued relative to DCF and significant upside potential

Key Metrics & Analysis

Financial Health

Revenue Growth71.40%
Profit Margin40.76%
P/E Ratio9.9
ROE51.93%
ROA21.41%
Debt/Equity37.14
P/B Ratio4.1
Op. Cash FlowZAC4.5B
Free Cash FlowZAC2.5B

Technical Analysis

TrendNeutral
RSI34.0
SupportZAC 63,235.00
ResistanceZAC 78,157.00
MA 20ZAC 70,985.30
MA 50ZAC 74,536.76
MA 200ZAC 73,024.82
MACDBearish
VolumeStable
Fear & Greed Index91.61

Valuation

Fair ValueZAC 9,963.99
Target PriceZAC 94,064.13
Upside/Downside47.16%
GradeUndervalued
TypeBlend
Dividend Yield3.99%

Risk Assessment

Beta0.37
Volatility50.59%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.